An independent study of the views of 83 UK-based patient groups on the corporate reputation of 15 pharmaceutical companies, and of the pharma industry as a whole, reported a lack of transparency at sharing clinical data. The study was conducted by PatientView, and collected the opinions of patient groups in a survey conducted between November 2017 and February 2018.

See the results of the survey in the PatientView Press Release